US2012065991A1PendingUtilityA1

System and methods for pharmacy management of drugs

Assignee: DAVIS MATTHEW WPriority: Oct 15, 2008Filed: Nov 22, 2011Published: Mar 15, 2012
Est. expiryOct 15, 2028(~2.3 yrs left)· nominal 20-yr term from priority
A61P 29/00A61K 31/165A61K 31/7048A61P 19/02A61P 19/06G16H 20/13G16H 70/40Y02A90/10
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein is a computer program product for pharmacy management and its application for using drugs that are P-glycoprotein or CYP3A4 inhibitors. Also included is a method of using a first drug in a patient receiving a prescription for the first drug. The computer program performs a method including issuing a drug-drug interaction alert when a patient is receiving a first drug and a concomitantly administered second drug.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A computer program product for pharmacy management, the computer program product comprising
 a computer readable storage medium having computer-readable executable instructions for:
 issuing a drug-drug interaction alert when a) a first drug identifier for a first drug is received and linked to a patient identifier so as to indicate that the first drug is to be administered to the patient and b) when the patient identifier is also linked to a second drug identifier indicating that a second drug is being concomitantly administered to the patient, wherein the drug-drug interaction alert indicates that the second drug is being concomitantly administered to the patient, 
 reviewing the patient's first drug dosing regimen prior to the first drug being dispensed, and 
 adjusting the patient's first drug dosing regimen responsive to the drug-drug interaction alert, so that the first drug is to be dispensed along with instructions for the first drug to be taken in accordance with an adjusted first drug dosing regimen 
 wherein the first drug is a substrate for both CYP 3A4 and P-glycoprotein, and 
 wherein the second drug is a CYP3A4 or P-glycoprotein inhibitor. 
   
     
     
         2 . The computer program product of  claim 1 , wherein the computer readable storage medium is non-transitory. 
     
     
         3 . The computer program product of  claim 1 , wherein the drug-drug interaction alert is issued to one or more of a pharmacy technician, a pharmacist, or a pharmacy customer. 
     
     
         4 . The computer program of  claim 1 , wherein the drug-drug interaction alert is issued as one or both of:
 a written warning on a display screen of the pharmacy management computer system, and   a printed warning attached to or packaged with the dispensed prescription.

Join the waitlist — get patent alerts

Track US2012065991A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.